Best Thymoma Doctors in Turkey for Australians

Professor Mustafa Solak gained specialised expertise at the MD Anderson Cancer Center – often ranked as the top cancer hospital globally. He now leads oncology cases at the JCI-accredited Hisar Hospital.

• Completed a minor specialisation at the Hacettepe University Cancer Institute
• Specialises in medical oncology for complex thoracic tumours
• Experienced in treating lung-related cancers using targeted drug therapies
• Focuses on personalized treatment plans based on a patient's specific tumour profile
• Active member in clinical research for gastrointestinal and head-neck cancers

Dr. Banu Atalar is a board-certified radiation oncologist (Türkiye, 2004). She is a Full Professor at Acibadem MAA University (2018–present) and a clinician at Anadolu Medical Center (2026–present). She trained at Istanbul and Cerrahpaşa. In 2011, she completed a Stanford clinical research fellowship in stereotactic radiosurgery. Her practice focuses on CNS, thoracic, and GI tumors. About 75% of her care involves SRS and MR‑guided adaptive SRS.

Her honors include the ASCO IDEA award (2004), the IASLC International Mentorship Award (2018), and H.FACR (2025). She has 72 international peer‑reviewed publications. Her leadership roles include President of the Turkish Society for Radiation Oncology (2025–27) and Chair of the ESTRO National Societies Committee (2024–27). She served on the ASCO Resource‑Stratified Guidelines Committee (2013–18) and on RSS meeting and nomination committees. She organized national congresses (2023, 2025) and has been an invited speaker at major meetings.

Prof. Hüseyin Baloğlu is a pathology specialist at Anadolu Medical Center in Gebze, Kocaeli, Turkey. He focuses on molecular pathology, surgical pathology, and tumour biopsy and diagnostics.

Education and accreditations: MD, GATA Medical School (1986). Pathology specialty training, GATA (1992). Associate Professor (Doçent), GATA (2004). Visiting scholar at Albert Einstein College of Medicine (New York) and Heidelberg University.

Achievements: author of over 600 peer‑reviewed publications. Holds a patent in molecular diagnostics for thyroid cancer. Leads liquid biopsy and precision oncology services.

Personal Information 

Sex:  Male

Born : 1968 

Professional Experience

Gayrettepe Florence Nigthingale Hospital

Medical Oncology Department

Besiktas/Istanbul/Turkey (ongoing)

Education:

He became Professor (22/April /2016)

Medical Oncology

Attending Phys.in Gastrointestinal Oncology (January 2005 ,2009)

Istanbul University Oncology Institue,

Department of Medical Oncology

Medical Oncology Fellowship (December 2001-December2004)

Istanbul University, Istanbul Medical Faculty

Hemodialysis Traning (May1996-January1997)

Istanbul University ,bCerrahpasa Medical Faculty

Internal Medicine Residency (November 1991-November 1996)

Istanbul University ,bCerrahpasa Medical Faculty

Ege University Medical Faculty (1985-1991)

Professional Experience

February 1999-November 2001

Metropolitan Florence Nigthingale Hospital

American Cancer Center, Gayrettepe/İstanbul

April1997- October 1998

Bayraktar Dialysis Center

Güngören/ Istanbul

Membership

Turkish Medical Oncology Association

ENET(European Neuroendocrine Tumour Society)

ESMO

ASCO

Personal information

Title: Professor Doctor

Branch: Radiation Oncology

Work History:

1 GATA Military Medical Faculty

2 Gayrettepe Florence Nightingale Hospital

3 T.R. Demiroğlu Bilim University \ Associate Professor

4 T.R Demiroğlu Bilim University \ Professor

Medical Specialties and Subspecialties:

1 Head and Neck Cancers

2 Radiation Oncology

Priority treatments:

1 Prostate cancer

2 Conformal treatments

Special advanced health technologies:

1 Truebeam Stx Technology

2 Halcyons

Education

1991 - Istanbul University Istanbul Faculty of Medicine

1996 - Istanbul University Cerrahpaşa Faculty of Medicine Radiation

Oncology Specialization Training

Associate Professor Hasan Mutlu leads medical oncology efforts at Medical Park Antalya, focusing on targeted therapies for organ tumours. He brings high-level academic expertise from his tenure at Akdeniz University Hospital.

• Specialises in targeted cancer therapies that attack specific cancer cells while sparing healthy tissue
• Uses immunotherapy to help the immune system recognise and destroy tumour cells
• Incorporates next-generation genetic research to customise treatment protocols for individual cases
• Integrates complementary medicine to support patient wellbeing during intensive chemotherapy cycles
• Trained at Hacettepe University, one of Turkey's most prestigious medical institutions

Associate Professor Abdullah Sakin is a leading medical oncologist at Medipol Bahçelievler University Hospital with a background in managing complex thoracic tumours.

• Former Head of the Medical Oncology Department at Yüzüncü Yıl University Faculty of Medicine
• Specialises in medical oncology, coordinating chemotherapy and targeted drug therapies for chest-based tumours
• Served as an Education Officer at Prof. Dr. Cemil Taşçıoğlu City Hospital, training next-generation cancer specialists
• Recognised specialist in internal medicine, providing a whole-of-body approach to cancer care

Dr. Rahib Hasanov is a medical oncologist. He graduated from Istanbul University Cerrahpaşa Faculty of Medicine (1999–2005). He completed an internal medicine residency (2009–2013) and a medical oncology fellowship at Marmara University (2015–2018). He also completed an observership at Houston Methodist Hospital (2006–2007).

He focuses on personalized oncology. His treatments include immunotherapy, targeted therapy, and novel agents. His clinical interests include gastrointestinal, breast, lung, and genitourinary cancers.

He attends national and international conferences. He welcomes patients from Turkey, Azerbaijan, Montenegro, Georgia, Uzbekistan, the Middle East, Europe, and the United States.

Dr. Mehmet Doğu Canoğlu is a radiation oncologist. He graduated from Kocaeli University Faculty of Medicine. He completed his residency in radiation oncology at Kocaeli University from 2006 to 2012.

He completed his compulsory service at Diyarbakır Training and Research Hospital. He then worked at Bağcılar Training and Research Hospital and at Medipol Mega University Hospital from 2015 to 2017. Since 2017, he has been a radiation oncologist at Anadolu Medical Center.

Professor Tahsin Ozadli is a medical oncology specialist at Valued Med Hub Hospitals with particular expertise in thoracic and gastrointestinal cancers.

• Trained at the Abdurrahman Yurtaslan Oncology Training and Research Hospital
• Specialises in managing lung tumours and cancers of the chest cavity
• Highly active in clinical research with extensive published work on Google Scholar
• Experienced in treating oesophageal and gastric cancers using modern protocols
• Expertise in gastrointestinal oncology focusing on complex digestive system cases

Professor Ozcan Yildiz is a specialist medical oncologist at Medipol Mega University Hospital with a focused interest in rare thoracic and neuroendocrine tumours.

• Published clinical reviews specifically on thymoma management and secondary complications like paraneoplastic syndromes
• Expert in managing neuroendocrine tumours – uses targeted drug therapies to control hormone-secreting growths
• Member of the Turkish Society of Medical Oncology, keeping his protocols aligned with international standards
• Active researcher with over 15 peer-reviewed publications in international medical journals

Professor of oncosurgery and proctology

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Associate Professor Nail Paksoy is an ESMO-certified medical oncologist specialising in complex thoracic and solid tumours at Medipol Bahçelievler University Hospital.

• Holds European Society for Medical Oncology (ESMO) Board Certification
• Expert in Peptide Receptor Radionuclide Therapy (PRRT) – targeted radiation for neuroendocrine tumours
• Sub-investigator for major international clinical trials with Roche and Pfizer
• Specialised fellowship training in allergy, immunology, and oncology
• Published extensive research on rare sarcoma and carcinoma outcomes

Professor Mustafa Serkan Alemdar is a dual-certified specialist in internal medicine and medical oncology at the Medical Park Antalya Hospital Complex.

• Specialises in managing thoracic tumours including thymoma cases
• Trained at Akdeniz University – a leading Turkish centre for medical oncology
• Focuses on systemic therapies to shrink tumours and prevent recurrence
• Expert in managing side effects of immunotherapy and chemotherapy treatments
• Practised at Antalya Training and Research Hospital as a senior oncologist

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.